6
Oct
2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
stand 6F43
Book a meeting

Resilience

About Resilience

Resilience is a North American contract development and manufacturing organization (CDMO) focused on delivering high-quality, scalable manufacturing solutions for advanced therapies. With capabilities spanning biologics drug substance and aseptic drug product manufacturing for both small and large molecules, Resilience partners with leading biopharma companies to bring complex medicines to market faster and more reliably.


Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
    stand 6F43
  • Country/Region:
    United States
  • Founded:
    2020
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Intermediates Manufacturer
Packaging & drug delivery
Pharmaceutical Company (innovator finished products)
Supply Chain
Technology
Contact info
Show contact info Hide contact info

Products from Resilience (5)

  • Large Molecule Biologics Development

    Product Large Molecule Biologics Development

    Modalities: monoclonal antibodies, Fab fragments, Fc fusion proteins, recombinant proteins, and ADC intermediates 

    Scale: pilot-scale single-use bioreactors from 3 L to 500 L for process development and characterization 

    Stage coverage: preclinical and early phase through la...
  • Device Assembly, Packaging & Logistics

    Product Device Assembly, Packaging & Logistics

    Device platforms: autoinjector, accessorized prefilled syringe, and cartridge assembly, supporting APFS, Ypsomed, and SHL platforms, plus additional device and proprietary platforms [TK: confirm current platform list] 

    Packaging: labeling, serialization, and aggregation across bulk, multi-u...
  • Drug Substance Manufacturing

    Product Drug Substance Manufacturing

    Modalities: monoclonal antibodies, recombinant proteins (including complex and non-cytotoxic conjugated), fusion proteins, enzymes, bispecifics, and plasma proteins 

    Scale: single-use bioreactors 3L to 500L (development) and 50L to 2,000L (manufacturing) 

    Stage coverage: pre...
  • Parenteral Drug Product Manufacturing

    Product Parenteral Drug Product Manufacturing

    Parenteral Formats: vials, accessorized prefilled syringes, autoinjectors, pen injectors, and cartridges 

    Formulation: parenteral aseptic liquid, including adjuvant, suspension, and other complex presentations 

    Finishing: 100% visual inspection, device assembly, packaging, s...
  • Sterile Fill/Finish

    Product Sterile Fill/Finish

    Formats: vials, pre-filled syringes, and cartridges 

    Fill technology: isolator- and RABS-based automated and semi-automated lines 

    Sites: Toronto and Cincinnati, both commercially licensed 

    Stage coverage: clinical and commercial, GMP and non-GMP 
    ...